Damora Therapeutics (DMRA) Other Working Capital Changes (2019 - 2026)
Damora Therapeutics (DMRA) reported Other Working Capital Changes of -$54000.0 for Q1 2026, down 1700.0% on a YoY basis from $3375.0 in Q1 2025, and down 107.69% quarter-over-quarter from -$26000.0 in Q4 2025.
Damora Therapeutics (DMRA) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Damora Therapeutics has reported Other Working Capital Changes for 8 years, with the latest figure at -$54000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 1700.0% year-over-year to -$54000.0; the trailing twelve-month figure through Mar 2026 stood at -$71000.0 (up 91.79% YoY), and the FY2025 full-year result was -$20000.0, up 97.9% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$54000.0, down from -$26000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $7.3 million in Q4 2022, with the low at -$6.6 million in Q2 2022.
- Historically, Other Working Capital Changes has averaged -$126529.4 across 5 years, with a median of -$79000.0 in 2023.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes slumped 2301.33% — and 2024, when it soared 625.68%.
- Damora Therapeutics' Other Working Capital Changes stood at $7.3 million in 2022, then slumped by 103.05% to -$222000.0 in 2023, then jumped by 625.68% to $1.2 million in 2024, then sank by 102.23% to -$26000.0 in 2025, then slumped by 107.69% to -$54000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$54000.0 (Q1 2026), -$26000.0 (Q4 2025), and $1000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Damora Therapeutics | 731.26 Mn | 528.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -54,000.00 |
| Mar 31, 2026 | -54,000.00 |
| Dec 31, 2025 | -26,000.00 |
| Dec 31, 2025 | -26,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | -3,000.00 |
| Mar 31, 2025 | -3,000.00 |
| Dec 31, 2024 | 1.17 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | -1.95 Mn |
| Sep 30, 2024 | -1.95 Mn |
| Jun 30, 2024 | -79,000.00 |
| Jun 30, 2024 | -79,000.00 |
| Mar 31, 2024 | -92,000.00 |
| Mar 31, 2024 | -92,000.00 |
| Dec 31, 2023 | -222,000.00 |
| Dec 31, 2023 | -222,000.00 |